Warszawski Uniwersytet Medyczny

Patent Applications and Registrations

Patent applications and USPTO patent grants for Warszawski Uniwersytet Medyczny.The latest application filed is for "modified amino acid derivatives for the treatment of neurological diseases and selected psychiatric disorders".

Company Profile

6.15.18

Warszawski Uniwersytet Medyczny - Warsaw N/A PL
WARSZAWSKI UNIWERSYTET MEDYCZNY - Warszawa PL
Warszawski Uniwersytet Medyczny - PL PL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
7-aminocephalosporanic acid derivative as inhibitor of IL15 and IL-2 activity Grant 11,452,728 - Koziak , et al. September 27, 2	2022-09-27
Modified Amino Acid Derivatives For The Treatment Of Neurological Diseases And Selected Psychiatric Disorders App 20220153694 - KAMINSKI; Krzysztof ; et al.	2022-05-19
(2,5-dioxopyrrolidin-1-yl)(phenyl)-acetamide Derivatives And Their Use In The Treatment Of Neurological Diseases App 20220073461 - KAMINSKI; Krzysztof ; et al.	2022-03-10
Urolithin A And A Composition Containing Same For External Use In Inflammations Of Various Etiologies App 20220062226 - PIWOWARSKI; Jakub ; et al.	2022-03-03
Methods for diagnosis, differentiation and monitoring using urine proteins as markers in IgA nephropathy Grant 11,029,314 - Mucha , et al. June 8, 2	2021-06-08
Oleacein For Use In Atherosclerosis Prevention App 20200237703 - FILIPEK; Agnieszka ; et al.	2020-07-30
Method of manufacturing intramedullary nails made of chitosan for long bones fractures treatment Grant 10,702,633 - Ciach , et al.	2020-07-07
Use Of Serum 2-cysteine Peroxiredoxins (2-cys-prdx) As Biomarkers Of Chronic Kidney Diseases App 20200064344 - MUCHA; Krzysztof ; et al.	2020-02-27
Methods For Diagnosis, Differentiation And Monitoring Using Urine Proteins As Markers In Iga Nephropathy App 20190339284 - MUCHA; Krzysztof ; et al.	2019-11-07
Protoescigenin derivative, process of its preparation, use of said compound and pharmaceutical composition comprising that compound Grant 10,370,404 - Koziak , et al.	2019-08-06
Methods of using T4 bacteriophage in treatment of adenoviral infections caused by HAdV-5 Grant 9,850,467 - Jakubowska-Zahorska , et al. December 26, 2	2017-12-26
Method Of Manufacturing Intramedullary Nails Made Of Chitosan For Long Bones Fractures Treatment App 20170354766 - CIACH; Tomasz ; et al.	2017-12-14
7-aminocephalosporanic Acid Derivative As Inhibitor Of Il-15 And Il-2 Activity App 20170319593 - Koziak; Katarzyna ; et al.	2017-11-09
Oleacein for treating or preventing diseases resulting from atherosclerotic plaques Grant 9,682,056 - Czerwinska , et al. June 20, 2	2017-06-20
Dental Ring App 20170151040 - Wychowanski; Piotr ; et al.	2017-06-01
7-aminocephalosporanic Acid Derivative As Inhibitor Of Il-15 And Il-2 Activity App 20160235762 - Koziak; Katarzyna ; et al.	2016-08-18
Use Of Bacteriophages App 20160122725 - Jakubowska-Zahorska; Renata ; et al.	2016-05-05
Oleacein For Treating Or Preventing Diseases Resulting From Atherosclerotic Plaques App 20160008311 - Czerwinska; Monika Ewa ; et al.	2016-01-14
Analgesic pharmaceutical composition for oral administration Grant 9,101,577 - Bujalska-Zadrozny , et al. August 11, 2	2015-08-11
Process for the preparation of protoescigenin Grant 9,073,813 - Gruza , et al. July 7, 2	2015-07-07
Esters of (acyloxymethyl)acrylamide, a pharmaceutical composition containing them, and their use as inhibitors of the thioredoxin--thioredoxin reductase system Grant 9,018,255 - Ostaszewski , et al. April 28, 2	2015-04-28
Analgesic Pharmaceutical Composition For Oral Administration App 20140127302 - Bujalska-Zadrozny; Magdalena ; et al.	2014-05-08
Process For The Preparation Of Protoescigenin App 20130190538 - GRUZA; Mariusz ; et al.	2013-07-25

Company Registrations

NCAGE Code	2018H	WARSZAWSKI UNIWERSYTET MEDYCZNY
CAGE Code	2018H	WARSZAWSKI UNIWERSYTET MEDYCZNY
S.A.M. Registration	2018H [366085723]	WARSZAWSKI UNIWERSYTET MEDYCZNY

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.